Northwestern Mutual Investment Management Company LLC boosted its stake in shares of Halyard Health, Inc. (NYSE:HYH) by 0.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,057 shares of the medical instruments supplier’s stock after purchasing an additional 14 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Halyard Health were worth $262,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of HYH. Capstone Asset Management Co. purchased a new stake in Halyard Health in the first quarter valued at about $203,000. Oregon Public Employees Retirement Fund raised its stake in Halyard Health by 1.2% in the first quarter. Oregon Public Employees Retirement Fund now owns 16,303 shares of the medical instruments supplier’s stock valued at $621,000 after buying an additional 200 shares during the last quarter. State Treasurer State of Michigan raised its stake in Halyard Health by 0.5% in the first quarter. State Treasurer State of Michigan now owns 18,920 shares of the medical instruments supplier’s stock valued at $721,000 after buying an additional 100 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in Halyard Health by 11.2% in the first quarter. State Board of Administration of Florida Retirement System now owns 32,077 shares of the medical instruments supplier’s stock valued at $1,222,000 after buying an additional 3,230 shares during the last quarter. Finally, American Century Companies Inc. purchased a new stake in Halyard Health in the first quarter valued at about $1,646,000. 91.02% of the stock is currently owned by institutional investors.

Shares of Halyard Health, Inc. (NYSE:HYH) opened at 45.92 on Wednesday. The firm has a 50-day moving average price of $43.72 and a 200-day moving average price of $39.69. Halyard Health, Inc. has a 1-year low of $31.59 and a 1-year high of $46.36. The stock has a market capitalization of $2.14 billion, a PE ratio of 44.15 and a beta of 1.76.

Halyard Health (NYSE:HYH) last released its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.14. The business had revenue of $399.20 million during the quarter, compared to analysts’ expectations of $399.16 million. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The business’s quarterly revenue was down .2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.45 EPS. On average, equities research analysts forecast that Halyard Health, Inc. will post $1.97 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/northwestern-mutual-investment-management-company-llc-buys-14-shares-of-halyard-health-inc-hyh/1574978.html.

A number of equities research analysts have commented on HYH shares. BidaskClub upgraded Halyard Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 19th. Deutsche Bank AG increased their price target on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 3rd. Stephens upgraded Halyard Health from an “equal weight” rating to an “overweight” rating in a research note on Thursday, August 3rd. Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price target for the company in a research note on Wednesday, July 12th. Finally, TheStreet upgraded Halyard Health from a “c” rating to a “b” rating in a research note on Thursday, June 22nd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $42.25.

Halyard Health Company Profile

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.